Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethicone dermal formulation for juvenile plantar dermatitis in children
IRCT20090808002306N9Phase 4Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dimeticone, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Foot dermatitis scale score, Age and 7 more. Started Mar 2024; status: completed.
02
Drugs
dimeticone
Beyond the preview
Go deeper on IRCT20090808002306N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090808002306N9.